Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.85)
# 3,205
Out of 5,173 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $27.62 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $25.61 | +168.45% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $2.55 | +174.51% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.88 | +1,613.31% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $1,080 | $7.66 | +13,999.22% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $84.65 | -58.65% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $20.59 | +142.84% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $2,470 → $1,520 | $4.64 | +32,658.62% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $9.72 | +980.25% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $42.88 | -32.37% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $5.08 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $27.62
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $25.61
Upside: +168.45%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $2.55
Upside: +174.51%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.88
Upside: +1,613.31%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $1,080
Current: $7.66
Upside: +13,999.22%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $84.65
Upside: -58.65%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $20.59
Upside: +142.84%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $2,470 → $1,520
Current: $4.64
Upside: +32,658.62%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $9.72
Upside: +980.25%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $42.88
Upside: -32.37%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $5.08
Upside: -